Chapter/Section Purchase

1 Compounded Bioidentical Hormone Therapy Market Overview
1.1 Product Overview and Scope of Compounded Bioidentical Hormone Therapy
1.2 Compounded Bioidentical Hormone Therapy Segment by Type
1.2.1 Global Compounded Bioidentical Hormone Therapy Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Oestrogen
1.2.3 Progesterone
1.2.4 Testosterone
1.3 Compounded Bioidentical Hormone Therapy Segment by Application
1.3.1 Global Compounded Bioidentical Hormone Therapy Sales Comparison by Application: (2022-2028)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Global Compounded Bioidentical Hormone Therapy Market Size Estimates and Forecasts
1.4.1 Global Compounded Bioidentical Hormone Therapy Revenue 2017-2028
1.4.2 Global Compounded Bioidentical Hormone Therapy Sales 2017-2028
1.4.3 Compounded Bioidentical Hormone Therapy Market Size by Region: 2017 Versus 2021 Versus 2028
2 Compounded Bioidentical Hormone Therapy Market Competition by Manufacturers
2.1 Global Compounded Bioidentical Hormone Therapy Sales Market Share by Manufacturers (2017-2022)
2.2 Global Compounded Bioidentical Hormone Therapy Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Compounded Bioidentical Hormone Therapy Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Compounded Bioidentical Hormone Therapy Manufacturing Sites, Area Served, Product Type
2.5 Compounded Bioidentical Hormone Therapy Market Competitive Situation and Trends
2.5.1 Compounded Bioidentical Hormone Therapy Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Compounded Bioidentical Hormone Therapy Players Market Share by Revenue
2.5.3 Global Compounded Bioidentical Hormone Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Compounded Bioidentical Hormone Therapy Retrospective Market Scenario by Region
3.1 Global Compounded Bioidentical Hormone Therapy Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Compounded Bioidentical Hormone Therapy Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Compounded Bioidentical Hormone Therapy Market Facts & Figures by Country
3.3.1 North America Compounded Bioidentical Hormone Therapy Sales by Country
3.3.2 North America Compounded Bioidentical Hormone Therapy Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Compounded Bioidentical Hormone Therapy Market Facts & Figures by Country
3.4.1 Europe Compounded Bioidentical Hormone Therapy Sales by Country
3.4.2 Europe Compounded Bioidentical Hormone Therapy Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Compounded Bioidentical Hormone Therapy Market Facts & Figures by Region
3.5.1 Asia Pacific Compounded Bioidentical Hormone Therapy Sales by Region
3.5.2 Asia Pacific Compounded Bioidentical Hormone Therapy Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Compounded Bioidentical Hormone Therapy Market Facts & Figures by Country
3.6.1 Latin America Compounded Bioidentical Hormone Therapy Sales by Country
3.6.2 Latin America Compounded Bioidentical Hormone Therapy Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Compounded Bioidentical Hormone Therapy Market Facts & Figures by Country
3.7.1 Middle East and Africa Compounded Bioidentical Hormone Therapy Sales by Country
3.7.2 Middle East and Africa Compounded Bioidentical Hormone Therapy Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Compounded Bioidentical Hormone Therapy Historic Market Analysis by Type
4.1 Global Compounded Bioidentical Hormone Therapy Sales Market Share by Type (2017-2022)
4.2 Global Compounded Bioidentical Hormone Therapy Revenue Market Share by Type (2017-2022)
4.3 Global Compounded Bioidentical Hormone Therapy Price by Type (2017-2022)
5 Global Compounded Bioidentical Hormone Therapy Historic Market Analysis by Application
5.1 Global Compounded Bioidentical Hormone Therapy Sales Market Share by Application (2017-2022)
5.2 Global Compounded Bioidentical Hormone Therapy Revenue Market Share by Application (2017-2022)
5.3 Global Compounded Bioidentical Hormone Therapy Price by Application (2017-2022)
6 Key Companies Profiled
6.1 SottoPelle
6.1.1 SottoPelle Corporation Information
6.1.2 SottoPelle Description and Business Overview
6.1.3 SottoPelle Compounded Bioidentical Hormone Therapy Sales, Revenue and Gross Margin (2017-2022)
6.1.4 SottoPelle Compounded Bioidentical Hormone Therapy Product Portfolio
6.1.5 SottoPelle Recent Developments/Updates
6.2 BioTE Medical
6.2.1 BioTE Medical Corporation Information
6.2.2 BioTE Medical Description and Business Overview
6.2.3 BioTE Medical Compounded Bioidentical Hormone Therapy Sales, Revenue and Gross Margin (2017-2022)
6.2.4 BioTE Medical Compounded Bioidentical Hormone Therapy Product Portfolio
6.2.5 BioTE Medical Recent Developments/Updates
6.3 Advantage Pharmaceuticals
6.3.1 Advantage Pharmaceuticals Corporation Information
6.3.2 Advantage Pharmaceuticals Description and Business Overview
6.3.3 Advantage Pharmaceuticals Compounded Bioidentical Hormone Therapy Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Advantage Pharmaceuticals Compounded Bioidentical Hormone Therapy Product Portfolio
6.3.5 Advantage Pharmaceuticals Recent Developments/Updates
6.4 Full Life Wellness Center
6.4.1 Full Life Wellness Center Corporation Information
6.4.2 Full Life Wellness Center Description and Business Overview
6.4.3 Full Life Wellness Center Compounded Bioidentical Hormone Therapy Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Full Life Wellness Center Compounded Bioidentical Hormone Therapy Product Portfolio
6.4.5 Full Life Wellness Center Recent Developments/Updates
6.5 Neuva Aesthetics
6.5.1 Neuva Aesthetics Corporation Information
6.5.2 Neuva Aesthetics Description and Business Overview
6.5.3 Neuva Aesthetics Compounded Bioidentical Hormone Therapy Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Neuva Aesthetics Compounded Bioidentical Hormone Therapy Product Portfolio
6.5.5 Neuva Aesthetics Recent Developments/Updates
6.6 Defy Medical
6.6.1 Defy Medical Corporation Information
6.6.2 Defy Medical Description and Business Overview
6.6.3 Defy Medical Compounded Bioidentical Hormone Therapy Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Defy Medical Compounded Bioidentical Hormone Therapy Product Portfolio
6.6.5 Defy Medical Recent Developments/Updates
6.7 Bio station
6.6.1 Bio station Corporation Information
6.6.2 Bio station Description and Business Overview
6.6.3 Bio station Compounded Bioidentical Hormone Therapy Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Bio station Compounded Bioidentical Hormone Therapy Product Portfolio
6.7.5 Bio station Recent Developments/Updates
6.8 Noven Pharmaceuticals
6.8.1 Noven Pharmaceuticals Corporation Information
6.8.2 Noven Pharmaceuticals Description and Business Overview
6.8.3 Noven Pharmaceuticals Compounded Bioidentical Hormone Therapy Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Noven Pharmaceuticals Compounded Bioidentical Hormone Therapy Product Portfolio
6.8.5 Noven Pharmaceuticals Recent Developments/Updates
6.9 Novartis AG
6.9.1 Novartis AG Corporation Information
6.9.2 Novartis AG Description and Business Overview
6.9.3 Novartis AG Compounded Bioidentical Hormone Therapy Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Novartis AG Compounded Bioidentical Hormone Therapy Product Portfolio
6.9.5 Novartis AG Recent Developments/Updates
6.10 Pfizer
6.10.1 Pfizer Corporation Information
6.10.2 Pfizer Description and Business Overview
6.10.3 Pfizer Compounded Bioidentical Hormone Therapy Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Pfizer Compounded Bioidentical Hormone Therapy Product Portfolio
6.10.5 Pfizer Recent Developments/Updates
6.11 TherapeuticsMD
6.11.1 TherapeuticsMD Corporation Information
6.11.2 TherapeuticsMD Compounded Bioidentical Hormone Therapy Description and Business Overview
6.11.3 TherapeuticsMD Compounded Bioidentical Hormone Therapy Sales, Revenue and Gross Margin (2017-2022)
6.11.4 TherapeuticsMD Compounded Bioidentical Hormone Therapy Product Portfolio
6.11.5 TherapeuticsMD Recent Developments/Updates
6.12 Bayer AG
6.12.1 Bayer AG Corporation Information
6.12.2 Bayer AG Compounded Bioidentical Hormone Therapy Description and Business Overview
6.12.3 Bayer AG Compounded Bioidentical Hormone Therapy Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Bayer AG Compounded Bioidentical Hormone Therapy Product Portfolio
6.12.5 Bayer AG Recent Developments/Updates
6.13 Novo Nordisk
6.13.1 Novo Nordisk Corporation Information
6.13.2 Novo Nordisk Compounded Bioidentical Hormone Therapy Description and Business Overview
6.13.3 Novo Nordisk Compounded Bioidentical Hormone Therapy Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Novo Nordisk Compounded Bioidentical Hormone Therapy Product Portfolio
6.13.5 Novo Nordisk Recent Developments/Updates
7 Compounded Bioidentical Hormone Therapy Manufacturing Cost Analysis
7.1 Compounded Bioidentical Hormone Therapy Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Compounded Bioidentical Hormone Therapy
7.4 Compounded Bioidentical Hormone Therapy Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Compounded Bioidentical Hormone Therapy Distributors List
8.3 Compounded Bioidentical Hormone Therapy Customers
9 Compounded Bioidentical Hormone Therapy Market Dynamics
9.1 Compounded Bioidentical Hormone Therapy Industry Trends
9.2 Compounded Bioidentical Hormone Therapy Market Drivers
9.3 Compounded Bioidentical Hormone Therapy Market Challenges
9.4 Compounded Bioidentical Hormone Therapy Market Restraints
10 Global Market Forecast
10.1 Compounded Bioidentical Hormone Therapy Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Compounded Bioidentical Hormone Therapy by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Compounded Bioidentical Hormone Therapy by Type (2023-2028)
10.2 Compounded Bioidentical Hormone Therapy Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Compounded Bioidentical Hormone Therapy by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Compounded Bioidentical Hormone Therapy by Application (2023-2028)
10.3 Compounded Bioidentical Hormone Therapy Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Compounded Bioidentical Hormone Therapy by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Compounded Bioidentical Hormone Therapy by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer